BURLINGTON…TriPath Imaging Inc. (Nasdaq:TPTH), says it expects to report second quarter earnings of up to a penny a share, racking up its first quarterly profits in its history.
TriPath says second quarter sales of $17 million, primarily of increased sales of its reagents, which are compounds that react with others in chemical analysis or experiments.
Paul R. Sohmer, M.D., chairman, president and CEO of TriPath said, “We have remained focused on our strategy to build reagent and disposable sales to drive margin, control operating expenses and cash burn, and prudently invest in our next generation of molecular oncology products.”
TriPath Imaging will host a conference call to discuss the Company’s full second quarter financial results on Thursday, August 5, 2004 at 11:00 a.m. Full financial results will be released prior to market open on August 5, 2004.
The call will be available by dialing (888) 344-3716. International participants should call (706) 634-4926.
